Theravance Biopharma Historical PE Ratio image   This TBPH PE ratio history page last updated 3/12/2024
Theravance Biopharma Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
2/26/2024
9.23-0.17-0.68NA
Q3 2023
11/7/2023
9.73-0.17-0.68NA
Q2 2023
8/7/2023
9.83-0.13-0.52NA
Q1 2023
5/8/2023
11.33-0.24-0.96NA
Q4 2022
2/27/2023
10.56-0.21-0.84NA
Q3 2022
11/7/2022
10.05-0.21-0.84NA
Q2 2022
8/4/2022
9.48-0.04-0.16NA
Q1 2022
5/5/2022
9.73-0.22-0.88NA
Q4 2021
2/23/2022
9.11-0.18-0.72NA
Q3 2021
11/3/2021
8.08-0.46-1.84NA
Q2 2021
8/3/2021
13.63-0.80-3.20NA
Q1 2021
5/4/2021
19.88-1.24-4.96NA
Q4 2020
2/23/2021
17.65-0.92-3.68NA
Q3 2020
11/5/2020
19.48-1.16-4.64NA
Q2 2020
8/6/2020
20.84-1.00-4.00NA
Q1 2020
5/6/2020
28.13-1.14-4.56NA
Q4 2019
2/24/2020
23.51-1.17-4.68NA
Q3 2019
11/5/2019
17.12-1.05-4.20NA
Q2 2019
7/31/2019
20.85-0.72-2.88NA
Q1 2019
5/7/2019
24.45-1.32-5.28NA
Q4 2018
2/26/2019
24.79-0.92-3.68NA
Q3 2018
11/6/2018
23.90-1.10-4.40NA
Q2 2018
8/1/2018
25.64-0.76-3.04NA
Q1 2018
5/8/2018
24.37-1.22-4.88NA
Q4 2017
2/27/2018
28.05-1.64-6.56NA
Q3 2017
11/7/2017
28.19-1.12-4.48NA
Q2 2017
8/8/2017
29.79-1.27-5.08NA
Q1 2017
5/9/2017
40.65-1.27-5.08NA
Q4 2016
2/27/2017
31.99-1.36-5.44NA
Q3 2016
11/8/2016
26.15-0.73-2.92NA
Q2 2016
8/8/2016
25.44-1.06-4.24NA
Q1 2016
5/9/2016
18.63-1.10-4.40NA
Q4 2015
3/9/2016
17.59-1.23-4.92NA
Q3 2015
11/9/2015
17.06-1.40-5.60NA
Q2 2015
8/10/2015
12.34-1.42-5.68NA
Q1 2015
5/7/2015
15.27-1.29-5.16NA
Q4 2014
3/10/2015
19.90-2.02-8.08NA
Q3 2014
11/6/2014
17.44-1.72-6.88NA
Q2 2014
8/13/2014
29.65-1.83-7.32NA
Theravance Biopharma PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
2/26/2024
9.23-0.17-0.71NA
Q3 2023
11/7/2023
9.73-0.17-0.75NA
Q2 2023
8/7/2023
9.83-0.13-0.79NA
Q1 2023
5/8/2023
11.33-0.24-0.70NA
Q4 2022
2/27/2023
10.56-0.21-0.68NA
Q3 2022
11/7/2022
10.05-0.21-0.65NA
Q2 2022
8/4/2022
9.48-0.04-0.90NA
Q1 2022
5/5/2022
9.73-0.22-1.66NA
Q4 2021
2/23/2022
9.11-0.18-2.68NA
Q3 2021
11/3/2021
8.08-0.46-3.42NA
Q2 2021
8/3/2021
13.63-0.80-4.12NA
Q1 2021
5/4/2021
19.88-1.24-4.32NA
Q4 2020
2/23/2021
17.65-0.92-4.22NA
Q3 2020
11/5/2020
19.48-1.16-4.47NA
Q2 2020
8/6/2020
20.84-1.00-4.36NA
Q1 2020
5/6/2020
28.13-1.14-4.08NA
Q4 2019
2/24/2020
23.51-1.17-4.26NA
Q3 2019
11/5/2019
17.12-1.05-4.01NA
Q2 2019
7/31/2019
20.85-0.72-4.06NA
Q1 2019
5/7/2019
24.45-1.32-4.10NA
Q4 2018
2/26/2019
24.79-0.92-4.00NA
Q3 2018
11/6/2018
23.90-1.10-4.72NA
Q2 2018
8/1/2018
25.64-0.76-4.74NA
Q1 2018
5/8/2018
24.37-1.22-5.25NA
Q4 2017
2/27/2018
28.05-1.64-5.30NA
Q3 2017
11/7/2017
28.19-1.12-5.02NA
Q2 2017
8/8/2017
29.79-1.27-4.63NA
Q1 2017
5/9/2017
40.65-1.27-4.42NA
Q4 2016
2/27/2017
31.99-1.36-4.25NA
Q3 2016
11/8/2016
26.15-0.73-4.12NA
Q2 2016
8/8/2016
25.44-1.06-4.79NA
Q1 2016
5/9/2016
18.63-1.10-5.15NA
Q4 2015
3/9/2016
17.59-1.23-5.34NA
Q3 2015
11/9/2015
17.06-1.40-6.13NA
Q2 2015
8/10/2015
12.34-1.42-6.45NA
Q1 2015
5/7/2015
15.27-1.29-6.86NA
Q4 2014
3/10/2015
19.90-2.02NANA
Q3 2014
11/6/2014
17.44-1.72NANA
Q2 2014
8/13/2014
29.65-1.83NANA
Quotes delayed 20 minutes

Email EnvelopeFree TBPH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Theravance Biopharma (TBPH) is categorized under the Miscellaneous sector; to help you further research PE history across stocks, below are some other companies in the same sector:

TLMD PE Ratio History
TNGX PE Ratio History
TOI PE Ratio History
TRTN PE Ratio History
TSE PE Ratio History
UBP PE Ratio History
UHG PE Ratio History
UPH PE Ratio History
URGN PE Ratio History
VLD PE Ratio History
How should the TBPH historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Theravance Biopharma. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this TBPH Historical PE Ratio page.

What is the average historical PE for TBPH based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The TBPH historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for TBPH based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The TBPH historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Theravance Biopharma Historical PE Ratio information for Theravance Biopharma' stock. The average TBPH historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average TBPH historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this TBPH historical PE result, against the recent PE: when this page was posted on 3/11/2024, the most recent closing price for TBPH had been 8.57, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on TBPH or any other given stock, valuation analysis for TBPH can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Theravance Biopharma PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for TBPH. Thanks for visiting, and the next time you need to research TBPH Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Healthcare Stocks Hedge Funds Are Selling, RAIN Options Chain, Funds Holding IGVT.

 

Theravance Biopharma Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.